267 related articles for article (PubMed ID: 7025959)
1. Do prostacyclin and thromboxane play a role in endotoxic shock?
Webb PJ; Westwick J; Scully MF; Zahavi J; Kakkar VV
Br J Surg; 1981 Oct; 68(10):720-4. PubMed ID: 7025959
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
Baba H
Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
[TBL] [Abstract][Full Text] [Related]
3. Relationship of TXB2 and 6-keto PGF1 alpha to the hemodynamic changes during baboon endotoxic shock.
Harris RH; Zmudka M; Maddox Y; Ramwell PW; Fletcher JR
Adv Prostaglandin Thromboxane Res; 1980; 7():843-9. PubMed ID: 6768234
[No Abstract] [Full Text] [Related]
4. [Plasma thromboxane B2 and capacity of the aorta to produce prostacyclin in arteriopathies of the lower extremities].
Jouve R; Rolland PH; Pellegrin E; Mercier C; Delboy C; Serradimigni A
J Mal Vasc; 1983; 8(3):221-5. PubMed ID: 6355348
[TBL] [Abstract][Full Text] [Related]
5. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.
Anderegg K; Anzeveno P; Cook JA; Halushka PV; McCarthy J; Wagner E; Wise WC
Br J Pharmacol; 1983 Apr; 78(4):725-32. PubMed ID: 6687819
[TBL] [Abstract][Full Text] [Related]
6. Changes of plasma levels of 6-keto-PGF1 alpha and TXB2 in rats during septic and endotoxic shock.
Tao YP; Chen HC; Xiao DM; Wang F
Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(1):37-40. PubMed ID: 3432249
[No Abstract] [Full Text] [Related]
7. Inhibition of endogenous thromboxane synthesis by exogenous prostacyclin during endotoxemia in conscious sheep.
Flynn JT; Demling RH
Adv Shock Res; 1982; 7():199-207. PubMed ID: 6753534
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin synthetase inhibition in group B streptococcal shock: hematologic and hemodynamic effects.
Peevy KJ; Panus P; Longenecker GL; Chartrand SA; Wiseman HJ; Boerth RC; Olson RD
Pediatr Res; 1986 Sep; 20(9):864-6. PubMed ID: 3092176
[TBL] [Abstract][Full Text] [Related]
9. Intestinal and arterial plasma thromboxane and prostacyclin levels in shock: effects of indomethacin.
Mózes T; Wieszt E
J Surg Res; 1989 Dec; 47(6):482-6. PubMed ID: 2511379
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Y-20811, a long-lasting thromboxane synthetase inhibitor, on endotoxin shock in rabbits.
Mikashima H; Muramoto Y
Thromb Res; 1990 Feb; 57(4):499-505. PubMed ID: 2326771
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
12. Effects of anisodamine on plasma levels of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) in rat with septic shock.
Tao YP; Xiao DM; Chen HC
Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):116-7. PubMed ID: 3194375
[No Abstract] [Full Text] [Related]
13. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
[TBL] [Abstract][Full Text] [Related]
14. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
Chiabrando C; Castagnoli MN; Noseda A; Fanelli R; Rajtar G; Cerletti C; de Gaetano G
Prostaglandins Leukot Med; 1984 Oct; 16(1):79-88. PubMed ID: 6440153
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
Halushka PV; Cook JA; Wise WC
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of 6-keto-prostaglandin F1 alpha, thromboxane B2 and platelet aggregation in patients with essential hypertension.
Chen LS; Ito T; Ogawa K; Shikano M; Satake T
Jpn Heart J; 1984 Nov; 25(6):1001-9. PubMed ID: 6549401
[TBL] [Abstract][Full Text] [Related]
17. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
Ritter JM
Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
[TBL] [Abstract][Full Text] [Related]
18. The potential role of thromboxane and prostacyclin in endotoxic and septic shock.
Cook JA; Wise WC; Butler RR; Reines HD; Rambo W; Halushka PV
Am J Emerg Med; 1984 Jan; 2(1):28-37. PubMed ID: 6440569
[TBL] [Abstract][Full Text] [Related]
19. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Hardee MM; Moore JN; Hardee GE
Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
[TBL] [Abstract][Full Text] [Related]
20. Changes of plasma 6-keto-PGF1 alpha and thromboxane B2 levels and platelet aggregation after tourniquet ischemia on the upper limb in normal subjects and patients with ischemic heart disease.
Chen LS; Ito T; Ogawa K; Satake T
Jpn Circ J; 1982 Jul; 46(7):651-6. PubMed ID: 6896534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
